Tenet Healthcare (THC) Current Deferred Revenue (2019 - 2023)

Tenet Healthcare (THC) has 5 years of Current Deferred Revenue data on file, last reported at $86.0 million in Q3 2023.

• Quarterly Current Deferred Revenue fell 22.52% year-over-year to $86.0 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $86.0 million (down 22.52% YoY) and the FY2022 annual result came in at $110.0 million, down 87.44% from the prior year.
• Current Deferred Revenue grew to $86.0 million in Q3 2023 per THC's latest filing, from $76.0 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $1.3 billion in Q2 2020, with the low at $56.0 million in Q4 2020.
• Average Current Deferred Revenue over 5 years is $287.6 million, with a median of $98.0 million recorded in 2021.
• The widest YoY moves for Current Deferred Revenue: up 1677.59% in 2021, down 91.63% in 2021.
• Tenet Healthcare's Current Deferred Revenue stood at $72.0 million in 2019, then slipped by 22.22% to $56.0 million in 2020, then soared by 1464.29% to $876.0 million in 2021, then plunged by 87.44% to $110.0 million in 2022, then fell by 21.82% to $86.0 million in 2023.
• Business Quant data shows THC's Current Deferred Revenue at $86.0 million in Q3 2023, $76.0 million in Q2 2023, and $76.0 million in Q1 2023.